06.10.2026

Webinar: Investigating sarcoplasmic reticulum Ca2+-ATPase using SSME

Part of the Beyond the Plasma Membrane webinar series. Explore all sessions

Date:  Wednesday, November 18, 2026
Time: 16:00 CET | 10:00 a.m. EST | 7:00 a.m. PST

How can SSM-based electrophysiology help uncover the transport mechanisms of intracellular membrane proteins?

Join Professor Francesco Tadini Buoninsegni from the University of Florence for a webinar exploring the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA), its role in intracellular calcium homeostasis, and how solid supported membrane (SSM)-based electrophysiology can provide mechanistic insights into its transport cycle and interactions with pharmacologically relevant compounds.

Agenda

  • Introduction
  • Professor Francesco Tadini Buoninsegni (University of Florence) - Investigating sarcoplasmic reticulum Ca2+-ATPase on solid supported membranes: from mechanistic insights to drug interactions
  • Discussion (Q&A session)
  • Closing words

Who should attend?

This webinar is relevant for researchers working in:

  • Membrane transport and transporter proteins
  • Calcium signaling and homeostasis
  • P-type ATPases
  • Membrane protein pharmacology
  • SSM-based electrophysiology
  • Drug discovery and assay development

👉 Register to join the live presentation and Q&A session.

Talk abstracts

Investigating sarcoplasmic reticulum Ca2+-ATPase on solid supported membranes: from mechanistic insights to drug interactions

Speaker: Francesco Tadini Buoninsegni , University of Florence

The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) belongs to the P-type ATPase family of membrane transport proteins. SERCA, which is found in the sarcoplasmic reticulum (SR) of muscle cells, couples ATP hydrolysis to the transport of two Ca2+ ions against their electrochemical potential gradient from the cytoplasm to the SR lumen, thus promoting muscle cell relaxation. SERCA maintains a low cytoplasmic Ca2+ concentration and contributes to intracellular calcium homeostasis which is essential for cell signaling and survival. Impaired SERCA function and regulation have been related to several diseases, such as cardiac and skeletal muscle diseases, neurodegenerative disorders, diabetes and cancer.

We have used an electrophysiological method based on a biomimetic membrane, the so-called solid supported membrane (SSM), to unravel key features of the SERCA transport mechanism. The SSM method allows label-free direct measurements of charge movements generated by the ATPase following adsorption of the membrane-bound enzyme to the SSM and chemical activation by a substrate concentration jump.

Electrical signals generated by SERCA were measured following Ca2+ and ATP jumps on SR vesicles adsorbed to the SSM. The measured charge movements are attributed to distinct electrogenic reaction steps in the SERCA transport cycle, i.e. binding of Ca2+ ions to the cytoplasmic side of the ATPase, and translocation and release of Ca2+ at the luminal side of the enzyme.

Because of its prominent role in intracellular calcium homeostasis and signaling, SERCA represents an attractive target for a variety of drugs. The effects of pharmacologically relevant compounds on the Ca2+ transport activity of SERCA were characterized using the SSM method. We found that these compounds affect calcium transport by SERCA and behave like inhibitors or activators of the enzyme. The molecular mechanism of action of a few selected drugs is discussed.

Finally, SSM-based electrophysiology has also been used to study other prominent members of the P-type ATPase family. In particular, we briefly discuss how the SSM method has contributed to investigating crucial aspects of the transport mechanism of a mammalian copper ATPase and a phospholipid flippase.